These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4979432)

  • 1. [Studies on antituberculotic activity of delta-hydroxy-gamma-oxo-L-norvaline (HON). 3. In vitro antituberculotic activity of HON in the combined use of various antituberculotic agents and mode of acquiring resistance in the interaction of drugs].
    Kamada M
    Bull Chest Dis Res Inst Kyoto Univ; 1968 Sep; 2(1):124-36 passim. PubMed ID: 4979432
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on antituberculous activity of lividomycin in vitro].
    Horai Z; Shimizu K; Yamamoto K; Fujisawa Y; Yamashita K
    Kekkaku; 1971 Oct; 46(10):401-4. PubMed ID: 5004573
    [No Abstract]   [Full Text] [Related]  

  • 3. [Observations on the chemo-antibiotic-resistance in vitro of more than 400 strains of Mycobacterium tuberculosis recently isolated].
    Spaziante G; Caroli G; Mazzarone R
    Riv Ital Ig; 1966; 26(5):512-34. PubMed ID: 4967921
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pattern of capreomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M; Toyama H
    Kekkaku; 1968 May; 43(5):161-4. PubMed ID: 4971952
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antitubercular effect of capreomycin in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antituberculosis activity of capreomycin. II].
    Wada T
    Kumamoto Igakkai Zasshi; 1967 Apr; 41(4):421-35. PubMed ID: 4964811
    [No Abstract]   [Full Text] [Related]  

  • 7. [Resistance pattern of Mycobacterium tuberculosis (H 37 Rv) to a new antibiotic, lividomycin].
    Tsukamura M; Mizuno S
    Kekkaku; 1972 Apr; 47(4):63-7. PubMed ID: 4627477
    [No Abstract]   [Full Text] [Related]  

  • 8. [Resistance of Mycobacterium tuberculosis to antituberculotic drugs in Czech Republic in 2003].
    Homolka J; Krejbich F; Havelková M
    Cas Lek Cesk; 2004; 143(12):836-9. PubMed ID: 15730215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibiotic resistance of Mycobacterium. Standard test method and its clinical use in Japan].
    Ushiba D
    Torax; 1966 Mar; 15(1):14-24. PubMed ID: 4957544
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biological and clinico-therapeutic importance of resistance].
    Maccacaro GA
    G Ital Chemioter; 1966; 13(1):3-10. PubMed ID: 4967320
    [No Abstract]   [Full Text] [Related]  

  • 11. [In vitro activities of antitubercular agents and intensification of combined chemotherapy of tuberculosis].
    Ooizumi K
    Kekkaku; 1983 Sep; 58(9):490-2. PubMed ID: 6420602
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of emetine hydrochloride on the growth of different mycobacteria strains].
    Schwartz E
    Zentralbl Bakteriol Orig; 1969 Dec; 212(1):115-25. PubMed ID: 4989350
    [No Abstract]   [Full Text] [Related]  

  • 13. [The experimental studies on antituberculous activity of lividomycin].
    Yamamoto K; Sakurai H; Inoue I; Yamagami K
    Kekkaku; 1972 May; 47(5):135-8. PubMed ID: 4339540
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug resistance of Mycobacterium tuberculosis of the avian type isolated from various animal species].
    Tyrina VS
    Probl Tuberk; 1972; 50(4):84-6. PubMed ID: 4623071
    [No Abstract]   [Full Text] [Related]  

  • 15. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. Influence of background factors, factors regarding the method of treatment and the course of the disease on the emergence of drug resistance].
    Yamamoto M; Nakamura H; Inagaki H
    Kekkaku; 1970 Oct; 45(10):349-57. PubMed ID: 4991618
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antituberculous action of a new antibiotic, Lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents].
    Tsukamura M; Mizuno S; Yamamoto M
    Kekkaku; 1970 Aug; 45(8):263-72. PubMed ID: 4989999
    [No Abstract]   [Full Text] [Related]  

  • 17. [New antitubercular drugs and their clinical use].
    Pregowski W
    Pol Tyg Lek; 1971 Feb; 26(7):244-7. PubMed ID: 4994370
    [No Abstract]   [Full Text] [Related]  

  • 18. The fundamental studies on antituberculous activities of lividomycin.
    Gomi J; Aoyagi T; Torikai K; Yamada Y; Fujino T
    Kekkaku; 1971 Jul; 46(7):265-9. PubMed ID: 4329783
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemo-antibiotic-resistance in vitro of "atypical" mycobacteria and Mycobacterium tuberculosis].
    Caroli G; Spaziante G; Mazzarone R
    Riv Ital Ig; 1966; 26(5):535-46. PubMed ID: 4967922
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action in vitro of antibacillar drug combinations on pluriresistant strains of tubercle bacilli].
    Kreis B; Fournaud S
    Rev Tuberc Pneumol (Paris); 1966 Apr; 30(4):445-60. PubMed ID: 4958256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.